532 related articles for article (PubMed ID: 29205441)
1. Hepatitis C transmission from seropositive, nonviremic donors to non-hepatitis C liver transplant recipients.
Bari K; Luckett K; Kaiser T; Diwan T; Cuffy M; Schoech MR; Safdar K; Blackard JT; Apewokin S; Paterno F; Sherman KE; Zucker SD; Anwar N; Shah SA
Hepatology; 2018 May; 67(5):1673-1682. PubMed ID: 29205441
[TBL] [Abstract][Full Text] [Related]
2. Use of Hepatitis C Virus Antibody-Positive Donor Livers in Hepatitis C Nonviremic Liver Transplant Recipients.
Luckett K; Kaiser TE; Bari K; Safdar K; Schoech MR; Apewokin S; Diwan TS; Cuffy MC; Anwar N; Shah SA
J Am Coll Surg; 2019 Apr; 228(4):560-567. PubMed ID: 30586641
[TBL] [Abstract][Full Text] [Related]
3. Renal transplantation from seropositive hepatitis C virus donors to seronegative recipients in Spain: a prospective study.
Franco A; Moreso F; Merino E; Sancho A; Kanter J; Gimeno A; Balibrea N; Rodriguez M; Perez Contreras F
Transpl Int; 2019 Jul; 32(7):710-716. PubMed ID: 30773693
[TBL] [Abstract][Full Text] [Related]
4. Prevention of viral transmission during lung transplantation with hepatitis C-viraemic donors: an open-label, single-centre, pilot trial.
Cypel M; Feld JJ; Galasso M; Pinto Ribeiro RV; Marks N; Kuczynski M; Kumar D; Bahinskaya I; Bagnato VS; Kurachi C; Slutsky AS; Yeung JC; Donahoe L; de Perrot M; Yasufuku K; Pierre A; Binnie M; Chaparro C; Martinu T; Chen M; Tikkanen J; Chow CW; Sidhu A; Waddell TK; Keshavjee S; Singer LG; Humar A
Lancet Respir Med; 2020 Feb; 8(2):192-201. PubMed ID: 31606437
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis C-positive donor liver transplantation for hepatitis C seronegative recipients.
Ting PS; Hamilton JP; Gurakar A; Urrunaga NH; Ma M; Glorioso J; King E; Toman LP; Wesson R; Garonzik-Wang J; Ottmann S; Philosophe B; Sulkowski M; Cameron AM; Durand CM; Chen PH
Transpl Infect Dis; 2019 Dec; 21(6):e13194. PubMed ID: 31609520
[TBL] [Abstract][Full Text] [Related]
6. Outcomes of hepatitis C virus seropositive donors to hepatitis C virus seronegative liver recipients: A large single center analysis.
Sobotka LA; Mumtaz K; Wellner MR; Kelly SG; Conteh LF; Hanje AJ; Schenk A; El-Hinnawi A; Black S; Washburn K; Pesavento T; Daloul R; Michaels AJ
Ann Hepatol; 2021; 24():100318. PubMed ID: 33515801
[TBL] [Abstract][Full Text] [Related]
7. Should organs from hepatitis C-positive donors be used in hepatitis C-negative recipients for liver transplantation?
Selzner N; Berenguer M
Liver Transpl; 2018 Jun; 24(6):831-840. PubMed ID: 29624894
[TBL] [Abstract][Full Text] [Related]
8. Liver, simultaneous liver-kidney, and kidney transplantation from hepatitis C-positive donors in hepatitis C-negative recipients: A single-center study.
Crismale JF; Khalid M; Bhansali A; De Boccardo G; Khaim R; Florman SS; Shapiro R; Schiano TD
Clin Transplant; 2020 Jan; 34(1):e13761. PubMed ID: 31808193
[TBL] [Abstract][Full Text] [Related]
9. Increasing Utilization and Excellent Initial Outcomes Following Liver Transplant of Hepatitis C Virus (HCV)-Viremic Donors Into HCV-Negative Recipients: Outcomes Following Liver Transplant of HCV-Viremic Donors.
Cotter TG; Paul S; Sandıkçı B; Couri T; Bodzin AS; Little EC; Sundaram V; Charlton M
Hepatology; 2019 Jun; 69(6):2381-2395. PubMed ID: 30706517
[TBL] [Abstract][Full Text] [Related]
10. Liver Transplant From Increased-Risk Donors in the Era of Direct-Acting Antivirals for Hepatitis C.
Shaikh OS; Rogal S; Malik A; Sharma V; Cacciarelli T
Exp Clin Transplant; 2020 Oct; 18(5):605-611. PubMed ID: 31324136
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C Virus NAT-Positive Solid Organ Allografts Transplanted Into Hepatitis C Virus-Negative Recipients: A Real-World Experience.
Kapila N; Menon KVN; Al-Khalloufi K; Vanatta JM; Murgas C; Reino D; Ebaid S; Shaw JJ; Agrawal N; Rhazouani S; Navas V; Sheffield C; Rahman AU; Castillo M; Lindenmeyer CC; Miller C; Quintini C; Zervos XB
Hepatology; 2020 Jul; 72(1):32-41. PubMed ID: 31659775
[TBL] [Abstract][Full Text] [Related]
12. Liver transplantation for hepatitis C virus (HCV) non-viremic recipients with HCV viremic donors.
Kwong AJ; Wall A; Melcher M; Wang U; Ahmed A; Subramanian A; Kwo PY
Am J Transplant; 2019 May; 19(5):1380-1387. PubMed ID: 30378723
[TBL] [Abstract][Full Text] [Related]
13. A controlled study of hepatitis C transmission by organ transplantation. The New England Organ Bank Hepatitis C Study Group.
Pereira BJ; Wright TL; Schmid CH; Levey AS
Lancet; 1995 Feb; 345(8948):484-7. PubMed ID: 7532254
[TBL] [Abstract][Full Text] [Related]
14. Outcomes following liver transplantation from HCV-seropositive donors to HCV-seronegative recipients.
Aqel B; Wijarnpreecha K; Pungpapong S; Taner CB; Reddy K; Leise M; Mi L; Dickson RC
J Hepatol; 2021 Apr; 74(4):873-880. PubMed ID: 33188903
[TBL] [Abstract][Full Text] [Related]
15. Successful treatment of donor-derived hepatitis C viral infection in three transplant recipients from a donor at increased risk for bloodborne pathogens.
Shah AP; Cameron A; Singh P; Frank AM; Fenkel JM
Transpl Infect Dis; 2017 Apr; 19(2):. PubMed ID: 28060446
[TBL] [Abstract][Full Text] [Related]
16. Use of HCV Ab+/NAT- donors in HCV naïve renal transplant recipients to expand the kidney donor pool.
Dao A; Cuffy M; Kaiser TE; Loethen A; Cafardi J; Luckett K; Rike AH; Cardi M; Alloway RR; Govil A; Diwan T; Sherman KE; Shah SA; Woodle ES
Clin Transplant; 2019 Jul; 33(7):e13598. PubMed ID: 31104346
[TBL] [Abstract][Full Text] [Related]
17. Pre-emptive pangenotypic direct acting antiviral therapy in donor HCV-positive to recipient HCV-negative heart transplantation: an open-label study.
Bethea ED; Gaj K; Gustafson JL; Axtell A; Lebeis T; Schoenike M; Turvey K; Coglianese E; Thomas S; Newton-Cheh C; Ibrahim N; Carlson W; Ho JE; Shah R; Nayor M; Gift T; Shao S; Dugal A; Markmann J; Elias N; Yeh H; Andersson K; Pratt D; Bhan I; Safa K; Fishman J; Kotton C; Myoung P; Villavicencio MA; D'Alessandro D; Chung RT; Lewis GD
Lancet Gastroenterol Hepatol; 2019 Oct; 4(10):771-780. PubMed ID: 31353243
[TBL] [Abstract][Full Text] [Related]
18. Early experience with the use of hepatitis C antibody-positive, nucleic acid testing-negative donors in lung transplantation.
Watson J; Mulvihill MS; Cox ML; Rich L; Wolfe CR; Gray A; Hartwig MG
Clin Transplant; 2019 Mar; 33(3):e13476. PubMed ID: 30609162
[TBL] [Abstract][Full Text] [Related]
19. The rise of the opioid epidemic and hepatitis C-positive organs: A new era in liver transplantation.
Gonzalez SA; Trotter JF
Hepatology; 2018 Apr; 67(4):1600-1608. PubMed ID: 29023920
[TBL] [Abstract][Full Text] [Related]
20. Heart and Lung Transplants from HCV-Infected Donors to Uninfected Recipients.
Woolley AE; Singh SK; Goldberg HJ; Mallidi HR; Givertz MM; Mehra MR; Coppolino A; Kusztos AE; Johnson ME; Chen K; Haddad EA; Fanikos J; Harrington DP; Camp PC; Baden LR;
N Engl J Med; 2019 Apr; 380(17):1606-1617. PubMed ID: 30946553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
